Literature DB >> 6715519

Epidemiological analysis of the significance of low-positive test results for antibody to hepatitis B surface and core antigens.

S C Hadler, B L Murphy, C A Schable, W L Heyward, D P Francis, M A Kane.   

Abstract

To determine the significance of certain serological test results commonly encountered in hepatitis B virus testing, we reviewed serological test data from nine studies of hepatitis B conducted between 1980 and 1982. Three tests, for hepatitis B surface antigen and for antibodies to hepatitis B surface antigen and hepatitis B core antigen (anti-HBs and anti-HBc), were used to measure hepatitis B virus infection risk in various populations. Two results, low levels of anti-HBs alone and low levels of anti-HBc alone, occurred at constant frequencies (2.72 and 0.4%, respectively), regardless of the prevalence of HBV infection in the population. Positivity for low levels of anti-HBs alone persisted for 1 year in less than one-half of those studied; in addition, response to hepatitis B virus vaccine was augmented in only one-third of this group. Positivity for low levels of anti-HBc alone did not persist in any of 11 persons studied. These findings indicate that presently available tests for anti-HBs and anti-HBc at low levels are often nonspecific and should be interpreted with caution.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6715519      PMCID: PMC271108          DOI: 10.1128/jcm.19.4.521-525.1984

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  7 in total

1.  Specificity of an assay for antibodies to hepatitis B surface antigen.

Authors:  N Nath; C T Fang; R Y Dodd
Journal:  Transfusion       Date:  1982 Jul-Aug       Impact factor: 3.157

2.  Hepatitis B immunity in hospital staff targeted for vaccination. Role of screening tests in immunization programs.

Authors:  G F Grady
Journal:  JAMA       Date:  1982-11-12       Impact factor: 56.272

3.  Viral hepatitis, type B. Studies on natural history and prevention re-examined.

Authors:  S Krugman; L R Overby; I K Mushahwar; C M Ling; G G Frösner; F Deinhardt
Journal:  N Engl J Med       Date:  1979-01-18       Impact factor: 91.245

4.  The prevention of hepatitis B with vaccine. Report of the centers for disease control multi-center efficacy trial among homosexual men.

Authors:  D P Francis; S C Hadler; S E Thompson; J E Maynard; D G Ostrow; N Altman; E H Braff; P O'Malley; D Hawkins; F N Judson; K Penley; T Nylund; G Christie; F Meyers; J N Moore; A Gardner; I L Doto; J H Miller; G H Reynolds; B L Murphy; C A Schable; B T Clark; J W Curran; A G Redeker
Journal:  Ann Intern Med       Date:  1982-09       Impact factor: 25.391

5.  Interpretation of various serological profiles of hepatitis B virus infection.

Authors:  I K Mushahwar; J L Dienstag; H F Polesky; L C McGrath; R H Decker; L R Overby
Journal:  Am J Clin Pathol       Date:  1981-12       Impact factor: 2.493

6.  Occupational exposure to hepatitis B virus in hospital personnel: infection or immunization?

Authors:  J L Dienstag; D M Ryan
Journal:  Am J Epidemiol       Date:  1982-01       Impact factor: 4.897

7.  Contrasting patterns and frequency of antibodies to the surface, core, and e antigens of hepatitis B virus in blood donors and in homosexual patients.

Authors:  R S Tedder; C H Cameron; R Wilson-Croome; D R Howell; A Colgrove; J A Barbara
Journal:  J Med Virol       Date:  1981       Impact factor: 2.327

  7 in total
  14 in total

1.  The frequency and significance of isolated hepatitis B core antibody and the suggested management of patients.

Authors:  K A Al-Mekhaizeem; M Miriello; A H Sherker
Journal:  CMAJ       Date:  2001-10-16       Impact factor: 8.262

2.  Improvement in the specificity of assays for detection of antibody to hepatitis B core antigen.

Authors:  J A Weare; E F Robertson; G Madsen; R Hu; R H Decker
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

3.  Characterization of a reduction-sensitive factor from human plasma responsible for apparent false activity in competitive assays for antibody to hepatitis B core antigen.

Authors:  E F Robertson; J A Weare; R Randell; P V Holland; G Madsen; R H Decker
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

4.  Reactivation of hepatitis B in an HIV-infected patient with antibodies against hepatitis B core antigen as the only serological marker.

Authors:  A J Chamorro; J L Casado; D Bellido; S Moreno
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-07       Impact factor: 3.267

5.  Transmission of hepatitis B virus from adopted Asian children to their American families.

Authors:  A Friede; J R Harris; J M Kobayashi; F E Shaw; P C Shoemaker-Nawas; M A Kane
Journal:  Am J Public Health       Date:  1988-01       Impact factor: 9.308

Review 6.  Exposure to hepatitis B: review of current concepts.

Authors:  F H Zimmerman; G P Wormser
Journal:  Bull N Y Acad Med       Date:  1989-09

7.  Comparative evaluation of commercial enzyme immunoassay kits for detection of hepatitis B seromarkers.

Authors:  S Ratnam; A M Tobin
Journal:  J Clin Microbiol       Date:  1987-02       Impact factor: 5.948

8.  Improved detection of hepatitis B virus surface antigen by a new rapid automated assay.

Authors:  B Weber; A Bayer; P Kirch; V Schlüter; D Schlieper; W Melchior
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

9.  Enzyme immunoassay for anti-hepatitis B core (HBc) immunoglobulin G1 and significance of low-level results in competitive assays for anti-HBc.

Authors:  M Sällberg; L O Magnius
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

10.  Hepatitis B infection in a day school for mentally retarded students: transmission from students to staff.

Authors:  R S Remis; M A Rossignol; M A Kane
Journal:  Am J Public Health       Date:  1987-09       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.